GLOW Blend peptide therapy consultations at Florida Surgery & Weight Loss Center are provided by Karla K
February 2, 2026: Gastroparesis is Most Common Injury in Lawsuits Against Ozempic and Other GLP-1 Drugs According to court documents, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims
Frequency depends on your individual risk factors, acetaminophen dose, and baseline liver health
Peptide therapy in Virginia Beach, VA offers targeted support for goals like metabolic balance, body composition, hormone optimization, and healthy aging
How to interpret the labs This stack combines pathways that can pull glucose interpretation in different directions